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The relationship between psychosocial factors and an increased risk for disease has been related to a heightened pro-inflammatory status reflected in increased circulating levels of pro-inflammatory cytokines and/or C-reactive protein (CRP). Routinely, epidemiological studies rely on measurements of inflammatory markers in serum or plasma, but the use of biological fluids such as saliva or oral mucosal transudate (OMT) may offer potential advantages. This study investigated correlations among plasma CRP and levels of IL-6 and soluble IL-6 receptor (sIL-6R) in plasma, saliva and OMT in a population of middle aged women with histories of past intimate partner violence (IPV). A total of 67 women without existing chronic diseases participated in the study, which included two visits each in which psychological tests were administered, and blood, saliva and OMT samples were collected. Although significantly higher plasma CRP levels were found in past IPV sufferers compared to controls, there were no significant differences in IL-6 or sIL-6R levels in plasma, saliva or OMT between the two groups. There were only relatively modest correlations between IL-6 levels in plasma and those in saliva or OMT and between plasma IL-6 and CRP levels. A significant correlation between IL-6 and sIL-6R levels in both saliva and OMT, but not in plasma, was also detected. No significant correlations were found between levels of IL-6 in saliva or OMT and periodontal health measures. Results indicate that IL-6 and sIL-6R levels in saliva or OMT do not closely reflect those in plasma, and therefore are not a good surrogate for systemic levels.
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Introduction
The existence of a relationship between psychosocial factors and an increased risk for disease and death has been well established (Hemingway and Marmot, 1999; Krause et al., 2004) . This risk has been shown to be associated with increased circulating levels of a variety of inflammatory markers, including pro-inflammatory cytokines such as tumor necrosis factor-a (TNFa), interleukin-1 (IL-1) and interleukin-6 (IL-6); soluble forms of several cytokine receptors such as soluble IL-6 receptors (sIL-6R) and soluble TNF receptors I and II ; and acute phase proteins such as C-reactive protein (CRP) (Papanicolaou et al., 1998; Harris et al., 1999; Maes, 1999; Appels et al., 2000; Ridker et al., 2002; Grassi-Oliveira et al., 2009) . The activation of the hypothalamicpituitary-adrenal (HPA) axis by these pro-inflammatory mediators is thought to be a contributing factor in the development of a variety of chronic inflammatory diseases (Lyson and McCann, 1991; Mastorakos et al., 1993; Kiecolt-Glaser et al., 2003; Danese et al., 2007; Davis et al., 2008) .
IL-6 is a pleiotropic cytokine involved not only in inflammatory responses but also in immune regulation, promoting antibody production and the differentiation of Th17 CD4+ T lymphocytes, a subset that has been associated with autoimmune disorders (Betelli et al., 2006) . Its importance in studies relating psychosocial factors and inflammatory mechanisms is based on the fact that IL-6 is considered a key cytokine in inflammatory responses and the major regulator of acute phase protein responses by the liver (Hirano et al., 1990; Ohzato et al., 1992; Kishimoto, 2005) . In addition, its levels in serum and plasma are more consistently detected and measured compared to other pro-inflammatory cytokines such as TNFa and IL-1. The levels of IL-6 in serum or plasma are increased in an array of pathologic conditions including both acute and chronic inflammatory diseases (Hirano et al., 1990) . Elevated systemic IL-6 levels have also been reported in association with a variety of health-related psychosocial factors such as chronic stress conditions, depression and low socioeconomic level, suggesting a potential association with a heightened inflammatory status 0889-1591/$ -see front matter Ó 2010 Elsevier Inc. All rights reserved. doi:10.1016/j.bbi.2010.09.023
